Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Intensity Therapeutics In...

    NASDAQ: INTS · Real-Time Price · USD
    0.33
    -0.25 (-43.01%)
    At close: Jun 12, 2025, 3:59 PM

    Intensity Therapeutics Statistics

    Share Statistics

    Intensity Therapeutics has 18.4M shares outstanding. The number of shares has increased by 10.71% in one year.

    Shares Outstanding

    n/a
    		 18.4M

    Shares Change (YoY)

    n/a
    		 10.71%

    Shares Change (QoQ)

    n/a
    		 0.5%

    Owned by Institutions (%)

    n/a
    		 19.56%

    Shares Floating

    n/a
    		 10.02M

    Failed to Deliver (FTD) Shares

    n/a
    		 2,086

    FTD / Avg. Volume

    n/a
    		 0.39%

    Short Selling Information

    The latest short interest is 157.65K, so 0.86% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 157.65K

    Short % of Shares Out

    n/a
    		 0.86%

    Short % of Float

    n/a
    		 1.13%

    Short Ratio (days to cover)

    n/a
    		 1

    Valuation Ratios

    The PE ratio is -1.5 and the forward PE ratio is -0.87. Intensity Therapeutics's PEG ratio is 0.1.

    PE Ratio

    n/a
    		 -1.5

    Forward PE

    n/a
    		 -0.87

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 0.1

    PB Ratio

    n/a
    		 8.39

    P/FCF Ratio

    n/a
    		 -1.61

    PEG Ratio

    n/a
    		 0.1
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Intensity Therapeutics.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.05.

    Current Ratio

    n/a
    		 1.92

    Quick Ratio

    n/a
    		 1.92

    Debt / Equity

    n/a
    		 0.05

    Debt / EBITDA

    n/a
    		 -0.01

    Debt / FCF

    n/a
    		 -0.01

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-3,253,600

    Employee Count

    n/a
    		 5

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -88.22% in the last 52 weeks. The beta is 4.32, so Intensity Therapeutics's price volatility has been higher than the market average.

    Beta

    n/a
    		 4.32

    52-Week Price Change

    n/a
    		 -88.22%

    50-Day Moving Average

    n/a
    		 0.95

    200-Day Moving Average

    n/a
    		 2.37

    Relative Strength Index (RSI)

    n/a
    		 48.77

    Average Volume (20 Days)

    n/a
    		 536,830

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -16.59M

    Net Income

    n/a
    		 -16.27M

    EBITDA

    n/a
    		 -16.24M

    EBIT

    n/a
    		 -16.27M

    Earnings Per Share (EPS)

    n/a
    		 -1.17
    Full Income Statement

    Balance Sheet

    The company has 2.59M in cash and 138K in debt, giving a net cash position of 2.45M.

    Cash & Cash Equivalents

    n/a
    		 2.59M

    Total Debt

    n/a
    		 138K

    Net Cash

    n/a
    		 2.45M

    Retained Earnings

    n/a
    		 -66.78M

    Total Assets

    n/a
    		 3.06M

    Working Capital

    n/a
    		 -978K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -15.22M and capital expenditures 0, giving a free cash flow of -15.22M.

    Operating Cash Flow

    n/a
    		 -15.22M

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -15.22M

    FCF Per Share

    n/a
    		 -1.09
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    INTS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for INTS is $8.5, which is 1391.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $8.5

    Price Target Difference

    n/a
    		 1391.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -47.42

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist